PDB Short entry for 3CSJ HEADER TRANSFERASE 09-APR-08 3CSJ TITLE HUMAN GLUTATHIONE S-TRANSFERASE P1-1 IN COMPLEX WITH CHLORAMBUCIL COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTATHIONE S-TRANSFERASE P; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GST CLASS-PI, GSTP1-1; COMPND 5 EC: 2.5.1.18; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 GENE: GSTP1, FAEES3, GST3; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: TOP10; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PGST-1 KEYWDS TRANSFERASE, GLUTATHIONE, DETOXIFICATION, CHLORAMBUCIL, POLYMORPHISM EXPDTA X-RAY DIFFRACTION AUTHOR L.J.PARKER REVDAT 3 30-AUG-23 3CSJ 1 REMARK REVDAT 2 24-FEB-09 3CSJ 1 VERSN REVDAT 1 01-JUL-08 3CSJ 0 SPRSDE 01-JUL-08 3CSJ 21GS JRNL AUTH L.J.PARKER,S.CICCONE,L.C.ITALIANO,A.PRIMAVERA,A.J.OAKLEY, JRNL AUTH 2 C.J.MORTON,N.C.HANCOCK,M.L.BELLO,M.W.PARKER JRNL TITL THE ANTI-CANCER DRUG CHLORAMBUCIL AS A SUBSTRATE FOR THE JRNL TITL 2 HUMAN POLYMORPHIC ENZYME GLUTATHIONE TRANSFERASE P1-1: JRNL TITL 3 KINETIC PROPERTIES AND CRYSTALLOGRAPHIC CHARACTERISATION OF JRNL TITL 4 ALLELIC VARIANTS. JRNL REF J.MOL.BIOL. V. 380 131 2008 JRNL REFN ISSN 0022-2836 JRNL PMID 18511072 JRNL DOI 10.1016/J.JMB.2008.04.066 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 14.92 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.9 REMARK 3 NUMBER OF REFLECTIONS : 33344 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.233 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1654 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2188 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.80 REMARK 3 BIN R VALUE (WORKING SET) : 0.2500 REMARK 3 BIN FREE R VALUE SET COUNT : 124 REMARK 3 BIN FREE R VALUE : 0.3800 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3276 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 331 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.51 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.37000 REMARK 3 B22 (A**2) : -0.20000 REMARK 3 B33 (A**2) : -0.70000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.02000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.157 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.153 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.096 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.195 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.920 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3389 ; 0.016 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4597 ; 1.543 ; 1.999 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 416 ; 5.454 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 150 ;32.115 ;24.800 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 566 ;16.594 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;15.037 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 508 ; 0.142 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2562 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1566 ; 0.202 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2285 ; 0.306 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 262 ; 0.126 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 45 ; 0.222 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 8 ; 0.223 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2156 ; 0.883 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3328 ; 1.314 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1432 ; 2.165 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1269 ; 3.228 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3CSJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-APR-08. REMARK 100 THE DEPOSITION ID IS D_1000047159. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUN-97 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33345 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.9 REMARK 200 DATA REDUNDANCY : 2.400 REMARK 200 R MERGE (I) : 0.04300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 19.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.23500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: 5GSS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: RESEVIOR SOLUTION CONTAINED: 25% (W/V) REMARK 280 AMMONIUM SULFATE, 60MM DTT, 100MM MES AND 10% (V/V) GLYCEROL. REMARK 280 SOLID CHLORAMBUCIL WAS STREAKED INTO THE DROP., PH 5.4, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 38.92000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.96500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 38.92000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 44.96500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3470 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18200 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -34.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 64 115.40 87.62 REMARK 500 TYR A 79 40.81 -143.13 REMARK 500 ASN A 110 67.48 -166.86 REMARK 500 THR A 141 -105.06 -119.87 REMARK 500 GLN B 64 117.70 91.67 REMARK 500 LEU B 78 52.94 -115.61 REMARK 500 TYR B 79 36.81 -145.88 REMARK 500 ASN B 110 36.82 -162.49 REMARK 500 THR B 141 -102.38 -115.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 210 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES B 210 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES A 211 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CBL B 211 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3CSH RELATED DB: PDB REMARK 900 GSTP1-1 WT (*A) COMPLEXED TO THE CHLORAMBUCIL-GLUTATHIONE CONJUGATE REMARK 900 RELATED ID: 3CSI RELATED DB: PDB REMARK 900 GSTP1-1 ALLELIC VARIANT *C (I104V/A113V) COMPLEXED TO THE REMARK 900 CHLORAMBUCIL-GLUTATHIONE CONJUGATE DBREF 3CSJ A 1 209 UNP P09211 GSTP1_HUMAN 2 210 DBREF 3CSJ B 1 209 UNP P09211 GSTP1_HUMAN 2 210 SEQRES 1 A 209 PRO PRO TYR THR VAL VAL TYR PHE PRO VAL ARG GLY ARG SEQRES 2 A 209 CYS ALA ALA LEU ARG MET LEU LEU ALA ASP GLN GLY GLN SEQRES 3 A 209 SER TRP LYS GLU GLU VAL VAL THR VAL GLU THR TRP GLN SEQRES 4 A 209 GLU GLY SER LEU LYS ALA SER CYS LEU TYR GLY GLN LEU SEQRES 5 A 209 PRO LYS PHE GLN ASP GLY ASP LEU THR LEU TYR GLN SER SEQRES 6 A 209 ASN THR ILE LEU ARG HIS LEU GLY ARG THR LEU GLY LEU SEQRES 7 A 209 TYR GLY LYS ASP GLN GLN GLU ALA ALA LEU VAL ASP MET SEQRES 8 A 209 VAL ASN ASP GLY VAL GLU ASP LEU ARG CYS LYS TYR ILE SEQRES 9 A 209 SER LEU ILE TYR THR ASN TYR GLU ALA GLY LYS ASP ASP SEQRES 10 A 209 TYR VAL LYS ALA LEU PRO GLY GLN LEU LYS PRO PHE GLU SEQRES 11 A 209 THR LEU LEU SER GLN ASN GLN GLY GLY LYS THR PHE ILE SEQRES 12 A 209 VAL GLY ASP GLN ILE SER PHE ALA ASP TYR ASN LEU LEU SEQRES 13 A 209 ASP LEU LEU LEU ILE HIS GLU VAL LEU ALA PRO GLY CYS SEQRES 14 A 209 LEU ASP ALA PHE PRO LEU LEU SER ALA TYR VAL GLY ARG SEQRES 15 A 209 LEU SER ALA ARG PRO LYS LEU LYS ALA PHE LEU ALA SER SEQRES 16 A 209 PRO GLU TYR VAL ASN LEU PRO ILE ASN GLY ASN GLY LYS SEQRES 17 A 209 GLN SEQRES 1 B 209 PRO PRO TYR THR VAL VAL TYR PHE PRO VAL ARG GLY ARG SEQRES 2 B 209 CYS ALA ALA LEU ARG MET LEU LEU ALA ASP GLN GLY GLN SEQRES 3 B 209 SER TRP LYS GLU GLU VAL VAL THR VAL GLU THR TRP GLN SEQRES 4 B 209 GLU GLY SER LEU LYS ALA SER CYS LEU TYR GLY GLN LEU SEQRES 5 B 209 PRO LYS PHE GLN ASP GLY ASP LEU THR LEU TYR GLN SER SEQRES 6 B 209 ASN THR ILE LEU ARG HIS LEU GLY ARG THR LEU GLY LEU SEQRES 7 B 209 TYR GLY LYS ASP GLN GLN GLU ALA ALA LEU VAL ASP MET SEQRES 8 B 209 VAL ASN ASP GLY VAL GLU ASP LEU ARG CYS LYS TYR ILE SEQRES 9 B 209 SER LEU ILE TYR THR ASN TYR GLU ALA GLY LYS ASP ASP SEQRES 10 B 209 TYR VAL LYS ALA LEU PRO GLY GLN LEU LYS PRO PHE GLU SEQRES 11 B 209 THR LEU LEU SER GLN ASN GLN GLY GLY LYS THR PHE ILE SEQRES 12 B 209 VAL GLY ASP GLN ILE SER PHE ALA ASP TYR ASN LEU LEU SEQRES 13 B 209 ASP LEU LEU LEU ILE HIS GLU VAL LEU ALA PRO GLY CYS SEQRES 14 B 209 LEU ASP ALA PHE PRO LEU LEU SER ALA TYR VAL GLY ARG SEQRES 15 B 209 LEU SER ALA ARG PRO LYS LEU LYS ALA PHE LEU ALA SER SEQRES 16 B 209 PRO GLU TYR VAL ASN LEU PRO ILE ASN GLY ASN GLY LYS SEQRES 17 B 209 GLN HET CL A 210 1 HET MES A 211 12 HET MES B 210 12 HET CBL B 211 19 HETNAM CL CHLORIDE ION HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HETNAM CBL CHLORAMBUCIL FORMUL 3 CL CL 1- FORMUL 4 MES 2(C6 H13 N O4 S) FORMUL 6 CBL C14 H19 CL2 N O2 FORMUL 7 HOH *331(H2 O) HELIX 1 1 ARG A 11 ARG A 13 5 3 HELIX 2 2 CYS A 14 GLN A 24 1 11 HELIX 3 3 THR A 34 GLY A 41 1 8 HELIX 4 4 GLY A 41 CYS A 47 1 7 HELIX 5 5 GLN A 64 GLY A 77 1 14 HELIX 6 6 ASP A 82 ASN A 110 1 29 HELIX 7 7 ASN A 110 GLN A 135 1 26 HELIX 8 8 ASN A 136 LYS A 140 5 5 HELIX 9 9 SER A 149 ALA A 166 1 18 HELIX 10 10 GLY A 168 ALA A 172 5 5 HELIX 11 11 PHE A 173 ALA A 185 1 13 HELIX 12 12 ARG A 186 SER A 195 1 10 HELIX 13 13 SER A 195 ASN A 200 1 6 HELIX 14 14 ARG B 11 ARG B 13 5 3 HELIX 15 15 CYS B 14 GLN B 24 1 11 HELIX 16 16 THR B 34 GLY B 41 1 8 HELIX 17 17 GLY B 41 CYS B 47 1 7 HELIX 18 18 GLN B 64 GLY B 77 1 14 HELIX 19 19 ASP B 82 ASN B 110 1 29 HELIX 20 20 ASN B 110 GLN B 135 1 26 HELIX 21 21 ASN B 136 LYS B 140 5 5 HELIX 22 22 SER B 149 ALA B 166 1 18 HELIX 23 23 PHE B 173 ALA B 185 1 13 HELIX 24 24 ARG B 186 SER B 195 1 10 HELIX 25 25 SER B 195 ASN B 200 1 6 SHEET 1 A 4 TRP A 28 VAL A 32 0 SHEET 2 A 4 TYR A 3 TYR A 7 1 N VAL A 5 O GLU A 31 SHEET 3 A 4 LYS A 54 ASP A 57 -1 O LYS A 54 N VAL A 6 SHEET 4 A 4 LEU A 60 TYR A 63 -1 O LEU A 62 N PHE A 55 SHEET 1 B 4 TRP B 28 VAL B 32 0 SHEET 2 B 4 TYR B 3 TYR B 7 1 N VAL B 5 O GLU B 31 SHEET 3 B 4 LYS B 54 ASP B 57 -1 O LYS B 54 N VAL B 6 SHEET 4 B 4 LEU B 60 TYR B 63 -1 O LEU B 62 N PHE B 55 CISPEP 1 LEU A 52 PRO A 53 0 6.73 CISPEP 2 PRO B 1 PRO B 2 0 -9.80 CISPEP 3 LEU B 52 PRO B 53 0 7.20 SITE 1 AC1 3 TYR A 7 GLY A 12 ARG A 13 SITE 1 AC2 4 TRP B 28 GLU B 30 PHE B 192 GLU B 197 SITE 1 AC3 5 ALA A 22 TRP A 28 GLU A 30 GLU A 197 SITE 2 AC3 5 ASP B 171 SITE 1 AC4 6 TYR B 7 PRO B 9 GLY B 12 ARG B 13 SITE 2 AC4 6 TYR B 108 GLY B 205 CRYST1 77.840 89.930 69.070 90.00 97.70 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012847 0.000000 0.001737 0.00000 SCALE2 0.000000 0.011120 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014610 0.00000